Compare $ALZN vs $KALA | Chartloom

Compare

$ALZN vs $KALA

Alzamend Neuro Inc · KALA BIO Inc

ALZN

Alzamend Neuro Inc

KALA

KALA BIO Inc

Compare $ALZN vs $KALA

Comparing Alzamend Neuro Inc and KALA BIO Inc

ALZNAlzamend Neuro Inc

KALAKALA BIO Inc

ALZNAlzamend Neuro Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-47.0%

FCF yield

-106.6%

KALAKALA BIO Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-99.1%

52W performance

-99.6%

FCF yield

-349.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALZN

KALA

Detailed metrics comparison

ALZN

Alzamend Neuro Inc

KALA

KALA BIO Inc

Market Cap

ALZN$6M

KALA$6M

Enterprise Value

ALZN$-1M

KALA$5M

Price

ALZN$1.34

KALA$0.29

P/E Ratio

ALZNN/A

KALAN/A

P/S Ratio

ALZN0.00x

KALA1.29x

EV/Sales

ALZN0.00x

KALA1.26x

EV/EBITDA

ALZN0.00x

KALA0.00x

P/B Ratio

ALZN1.14x

KALA0.82x

P/FCF Ratio

ALZNN/A

KALAN/A

EV/FCF

ALZN0.17x

KALA-0.27x

PEG Ratio

ALZNN/A

KALAN/A

Forward P/E (NTM)

ALZNN/A

KALAN/A

Forward P/S (NTM)

ALZNN/A

KALAN/A

Revenue (TTM)

ALZN$0

KALA$0

Revenue Growth (YoY)

ALZNN/A

KALAN/A

Forward Rev Growth

ALZN0.0%

KALA0.0%

Gross Margin (TTM)

ALZN0.0%

KALA31.0%

Operating Margin (TTM)

ALZN0.0%

KALA0.0%

EBITDA Margin (TTM)

ALZN0.0%

KALA0.0%

Net Margin (TTM)

ALZN0.0%

KALA0.0%

FCF Margin (TTM)

ALZNN/A

KALAN/A

Net Income (TTM)

ALZN$-9M

KALA$-10M

FCF (TTM)

ALZN$-7M

KALA$-20M

EPS (TTM)

ALZN-$2.03

KALA-$135.85

ROE (TTM)

ALZN-27788.0%

KALA-2816.0%

ROA (TTM)

ALZN-18419.0%

KALA-7023.0%

ROIC (TTM)

ALZN-27788.0%

KALA-2816.0%

Cash

ALZN$8M

KALA$229K

Debt

ALZN$0

KALA$0

Net Cash/Debt

ALZN$8M

KALA$229K

Current Ratio (TTM)

ALZN3.01x

KALA6.88x

Quick Ratio (TTM)

ALZN2.77x

KALA4.84x

Debt/Equity (TTM)

ALZN0.00x

KALA2.47x

Debt/Assets (TTM)

ALZN0.0%

KALA0.0%

Interest Coverage (TTM)

ALZNN/A

KALAN/A

Net Debt/EBITDA (TTM)

ALZN0.00x

KALA0.00x

Beta

ALZN0.43

KALA-2.48

52W Performance

ALZN-47.0%

KALA-99.6%

YTD Performance

ALZN-29.5%

KALA-99.1%

% from 52W High

ALZN-50.0%

KALA-99.7%

% from 52W Low

ALZN59.5%

KALA2.8%

Asset Turnover (TTM)

ALZN0.00x

KALA0.05x

FCF Yield (TTM)

ALZN-106.6%

KALA-349.4%

Earnings Yield (TTM)

ALZN-141.7%

KALA-177.3%

Dividend Yield (TTM)

ALZNN/A

KALAN/A

Rule of 40

ALZN0.0

KALA0.0

EV/GP/RG

ALZNN/A

KALAN/A

Ticker research

View ALZN research View KALA research

Metric	ALZN Alzamend Neuro Inc	KALA KALA BIO Inc
Market & Valuation
Market Cap	$6M	$6M
Enterprise Value	$-1M	$5M
Price	$1.34	$0.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.29x
EV/Sales	0.00x	1.26x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.14x	0.82x
P/FCF Ratio	N/A	N/A
EV/FCF	0.17x	-0.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	31.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-9M	$-10M
FCF (TTM)	$-7M	$-20M
EPS (TTM)	-$2.03	-$135.85
ROE (TTM)	-27788.0%	-2816.0%
ROA (TTM)	-18419.0%	-7023.0%
ROIC (TTM)	-27788.0%	-2816.0%
Financial Health
Cash	$8M	$229K
Debt	$0	$0
Net Cash/Debt	$8M	$229K
Current Ratio (TTM)	3.01x	6.88x
Quick Ratio (TTM)	2.77x	4.84x
Debt/Equity (TTM)	0.00x	2.47x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.43	-2.48
52W Performance	-47.0%	-99.6%
YTD Performance	-29.5%	-99.1%
% from 52W High	-50.0%	-99.7%
% from 52W Low	59.5%	2.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-106.6%	-349.4%
Earnings Yield (TTM)	-141.7%	-177.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALZN research	View KALA research

Valuation

P/S Ratio

ALZN

0.00x

KALA

1.29x

EV/FCF

KALA

-0.27x

ALZN

0.17x

Growth & revenue

Forward Revenue Growth

ALZN

0.0%

KALA

0.0%

Profitability & performance

Gross Margin

KALA

31.0%

ALZN

0.0%

ROE

KALA

-2816.0%

ALZN

-27788.0%

FCF Yield %

ALZN

-106.6%

KALA

-349.4%

52-Week Performance

ALZN

-47.0%

KALA

-99.6%

Detailed metrics comparison

ALZN

Alzamend Neuro Inc

KALA

KALA BIO Inc

Market Cap

ALZN$6M

KALA$6M

Enterprise Value

ALZN$-1M

KALA$5M

Price

ALZN$1.34

KALA$0.29

P/E Ratio

ALZNN/A

KALAN/A

P/S Ratio

ALZN0.00x

KALA1.29x

EV/Sales

ALZN0.00x

KALA1.26x

EV/EBITDA

ALZN0.00x

KALA0.00x

P/B Ratio

ALZN1.14x

KALA0.82x

P/FCF Ratio

ALZNN/A

KALAN/A

EV/FCF

ALZN0.17x

KALA-0.27x

PEG Ratio

ALZNN/A

KALAN/A

Forward P/E (NTM)

ALZNN/A

KALAN/A

Forward P/S (NTM)

ALZNN/A

KALAN/A

Revenue (TTM)

ALZN$0

KALA$0

Revenue Growth (YoY)

ALZNN/A

KALAN/A

Forward Rev Growth

ALZN0.0%

KALA0.0%

Gross Margin (TTM)

ALZN0.0%

KALA31.0%

Operating Margin (TTM)

ALZN0.0%

KALA0.0%

EBITDA Margin (TTM)

ALZN0.0%

KALA0.0%

Net Margin (TTM)

ALZN0.0%

KALA0.0%

FCF Margin (TTM)

ALZNN/A

KALAN/A

Net Income (TTM)

ALZN$-9M

KALA$-10M

FCF (TTM)

ALZN$-7M

KALA$-20M

EPS (TTM)

ALZN-$2.03

KALA-$135.85

ROE (TTM)

ALZN-27788.0%

KALA-2816.0%

ROA (TTM)

ALZN-18419.0%

KALA-7023.0%

ROIC (TTM)

ALZN-27788.0%

KALA-2816.0%

Cash

ALZN$8M

KALA$229K

Debt

ALZN$0

KALA$0

Net Cash/Debt

ALZN$8M

KALA$229K

Current Ratio (TTM)

ALZN3.01x

KALA6.88x

Quick Ratio (TTM)

ALZN2.77x

KALA4.84x

Debt/Equity (TTM)

ALZN0.00x

KALA2.47x

Debt/Assets (TTM)

ALZN0.0%

KALA0.0%

Interest Coverage (TTM)

ALZNN/A

KALAN/A

Net Debt/EBITDA (TTM)

ALZN0.00x

KALA0.00x

Beta

ALZN0.43

KALA-2.48

52W Performance

ALZN-47.0%

KALA-99.6%

YTD Performance

ALZN-29.5%

KALA-99.1%

% from 52W High

ALZN-50.0%

KALA-99.7%

% from 52W Low

ALZN59.5%

KALA2.8%

Asset Turnover (TTM)

ALZN0.00x

KALA0.05x

FCF Yield (TTM)

ALZN-106.6%

KALA-349.4%

Earnings Yield (TTM)

ALZN-141.7%

KALA-177.3%

Dividend Yield (TTM)

ALZNN/A

KALAN/A

Rule of 40

ALZN0.0

KALA0.0

EV/GP/RG

ALZNN/A

KALAN/A

Ticker research

View ALZN research View KALA research

Metric	ALZN Alzamend Neuro Inc	KALA KALA BIO Inc
Market & Valuation
Market Cap	$6M	$6M
Enterprise Value	$-1M	$5M
Price	$1.34	$0.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.29x
EV/Sales	0.00x	1.26x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.14x	0.82x
P/FCF Ratio	N/A	N/A
EV/FCF	0.17x	-0.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	31.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-9M	$-10M
FCF (TTM)	$-7M	$-20M
EPS (TTM)	-$2.03	-$135.85
ROE (TTM)	-27788.0%	-2816.0%
ROA (TTM)	-18419.0%	-7023.0%
ROIC (TTM)	-27788.0%	-2816.0%
Financial Health
Cash	$8M	$229K
Debt	$0	$0
Net Cash/Debt	$8M	$229K
Current Ratio (TTM)	3.01x	6.88x
Quick Ratio (TTM)	2.77x	4.84x
Debt/Equity (TTM)	0.00x	2.47x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.43	-2.48
52W Performance	-47.0%	-99.6%
YTD Performance	-29.5%	-99.1%
% from 52W High	-50.0%	-99.7%
% from 52W Low	59.5%	2.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-106.6%	-349.4%
Earnings Yield (TTM)	-141.7%	-177.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALZN research	View KALA research